- Vaccines,
- Anti-infectives,
- Anti-parasites,
- Anti-inflammatory,
- Supplemental Feed Additives
- Others
Australia Equine Healthcare Market Segmentation
By Product Type
By Dosage Form
- Injectables,
- Injectables/Oral Solution,
- Tablets
- Others
By Application
- Inflammatory Diseases,
- Infectious Diseases,
- Asthma,
- Parasites
- Others
By End User
- Companion Animal Clinics,
- Veterinary Hospitals
- Others
Frequently Asked Questions
2023 is the base year and 2030 is the forecast year.
In our report, we provide market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
| 1. Executive Summary |
| 2. Australia Equine Healthcare Market Introduction |
| 2.1. Australia Equine Healthcare Market Taxonomy |
| 2.2. Australia Equine Healthcare Market Definitions |
| 2.2.1. Product Type |
| 2.2.2. Dosage Form |
| 2.2.3. Application |
| 2.2.4. End User |
| 3. Australia Equine Healthcare Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Australia Equine Healthcare Market Competition Landscape |
| 4. Australia Equine Healthcare Market Analysis, 2019-2023 and Forecast, 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Australia Equine Healthcare Market, By Product Type, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.1. Vaccines |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Anti-infectives |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Anti-parasites |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Anti-inflammatory |
| 5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Supplemental Feed Additives |
| 5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Others |
| 5.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Australia Equine Healthcare Market Forecast, By Dosage Form, 2019-2023 and Forecast, 2024-2030 |
| 6.1. Injectables |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Injectables/Oral Solution |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Tablets |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Australia Equine Healthcare Market Forecast, By Application, 2019-2023 and Forecast, 2024-2030 |
| 7.1. Inflammatory Diseases |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Infectious Diseases |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asthma |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Parasites |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Australia Equine Healthcare Market Forecast, By End User, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.1. Companion Animal Clinics |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Veterinary Hospitals |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Others |
| 8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Australia Equine Healthcare Market - Opportunity Analysis Index, By Product Type, Dosage Form, Application, and End User, 2024-2030 |
| 9. Competition Landscape |
| 9.1. Strategic Dashboard of Top Market Players |
| 9.2. Company Profiles (Introduction, Financial Analysis, Dosage Form & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 9.2.1. Zoetis,Inc. |
| 9.2.2. Virbac Corporation |
| 9.2.3. Boehringer Ingelheim |
| 9.2.4. Merck & Co., Inc. |
| 9.2.5. Sypharma Pty. Ltd. |
| 9.2.6. Abbey Animal Health Pty Ltd. |
| 9.2.7. Jurox Pty Ltd. |
| 9.2.8. TRM Equine Nutrition |
| 9.2.9. Ceva Animal Health Pty Ltd. |
| 9.2.10. Luoda Pharma |
| 10. Research Methodology |
| 11. Key Assumptions and Acronyms |
- Zoetis,Inc.
- Virbac Corporation
- Boehringer Ingelheim
- Merck & Co., Inc.
- Sypharma Pty. Ltd.
- Abbey Animal Health Pty Ltd.
- Jurox Pty Ltd.
- TRM Equine Nutrition
- Ceva Animal Health Pty Ltd.
- Luoda Pharma